Lithotripsy Market

Key Players: Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Olympus Corporation (JP), Richard Wolf GmbH (DE), Cook Medical (US), ConMed Corporation (US), Stryker Corporation (US), B. Braun Melsungen AG (DE)

Lithotripsy Market

Lithotripsy Market Size, Growth Research Report By Procedure Type (Extracorporeal Shock Wave Lithotripsy, Laser Lithotripsy, Percutaneous Lithotripsy, Ureteroscopic Lithotripsy), By Technology (Electromechanical Lithotripters, Laser Lithotripters, Ultrasound Lithotripters), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Stone Type (Calcium Oxalate Stones, Uric Acid Stones, Struvite Stones) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Competitor Industry Analysis and Trends Forecast Till 2035
ID: MRFR/MED/2309-HCR
72 Pages
Satyendra Maurya, Rahul Gotadki
Last Updated: May 15, 2026
Request Free Sample

Lithotripsy Market Summary

As per MRFR analysis, the Lithotripsy Market Size was estimated at 1749.33 USD Million in 2024. The Lithotripsy industry is projected to grow from 1859.47 USD Million in 2025 to 3052.63 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.15% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The lithotripsy market is poised for growth driven by technological advancements and increasing healthcare needs.

  • North America remains the largest market for lithotripsy, driven by advanced healthcare infrastructure and high patient awareness.
  • Asia-Pacific is emerging as the fastest-growing region, fueled by rising healthcare investments and a growing population.
  • Renal stones represent the largest segment in the lithotripsy market, while ureteral stones are experiencing the fastest growth due to increasing incidence rates.
  • Key market drivers include the rising incidence of urolithiasis and technological innovations in lithotripsy, which enhance treatment efficacy.

Market Size & Forecast

2024 Market Size 1749.33 (USD Million)
2035 Market Size 3052.63 (USD Million)
CAGR (2025 - 2035) 5.15%

Major Players

Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Olympus Corporation (JP), Richard Wolf GmbH (DE), Cook Medical (US), ConMed Corporation (US), Stryker Corporation (US), B. Braun Melsungen AG (DE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Lithotripsy Market Trends

The Lithotripsy Market is currently experiencing notable transformations driven by advancements in technology and increasing awareness regarding kidney stone management. The integration of innovative techniques, such as laser lithotripsy, is enhancing treatment efficacy and patient outcomes. Furthermore, the rising prevalence of urolithiasis, coupled with a growing geriatric population, is propelling demand for lithotripsy procedures. Healthcare providers are increasingly adopting minimally invasive methods, which are perceived to offer reduced recovery times and lower complication rates. This shift towards patient-centric care is reshaping the landscape of the Lithotripsy Market, as stakeholders seek to improve service delivery and operational efficiency. In addition, the competitive dynamics within the Lithotripsy Market are evolving, with a surge in collaborations and partnerships among key players. These alliances aim to foster research and development initiatives, ultimately leading to the introduction of advanced lithotripsy devices. Moreover, regulatory bodies are playing a crucial role in ensuring the safety and effectiveness of these technologies, which may further influence market growth. As the industry adapts to these changes, it appears poised for sustained expansion, driven by continuous innovation and a focus on enhancing patient care.

Technological Advancements

The Lithotripsy Market is witnessing rapid technological advancements, particularly in the development of laser lithotripsy systems. These innovations are enhancing the precision and effectiveness of stone fragmentation, leading to improved patient outcomes and satisfaction.

Minimally Invasive Procedures

There is a growing trend towards minimally invasive lithotripsy procedures, which are favored for their reduced recovery times and lower complication rates. This shift reflects a broader movement in healthcare towards patient-centric treatment options.

Collaborative Efforts in Research

The Lithotripsy Market is characterized by increased collaborations among manufacturers, healthcare providers, and research institutions. These partnerships are aimed at advancing the development of new technologies and improving treatment protocols.

Lithotripsy Market Drivers

Rising Incidence of Urolithiasis

The increasing prevalence of urolithiasis, or kidney stones, is a primary driver of the Global Lithotripsy Market Industry. As reported, approximately 10% of the global population experiences kidney stones at some point in their lives. This condition is particularly prevalent in developed nations, where lifestyle factors contribute to its rise. The demand for effective treatment options, such as lithotripsy, is expected to grow as more individuals seek medical intervention. Consequently, the Global Lithotripsy Market Industry is projected to reach 3.32 USD Billion in 2024, reflecting the urgent need for advanced lithotripsy technologies.

Growing Awareness and Patient Education

The rise in awareness regarding kidney health and the importance of timely treatment for kidney stones is propelling the Global Lithotripsy Market Industry. Educational campaigns by healthcare organizations and government initiatives are informing the public about the risks associated with untreated urolithiasis. This heightened awareness is likely to lead to increased patient consultations and a subsequent rise in lithotripsy procedures. As more patients seek effective treatments, the market is expected to expand, contributing to the projected growth of the Global Lithotripsy Market Industry, which is set to reach 5.48 USD Billion by 2035.

Technological Advancements in Lithotripsy

Technological innovations in lithotripsy equipment are significantly enhancing treatment efficacy and patient outcomes, thus driving the Global Lithotripsy Market Industry. The introduction of more precise and less invasive lithotripsy devices, such as laser lithotripsy systems, allows for improved stone fragmentation and reduced recovery times. These advancements not only increase the appeal of lithotripsy as a treatment option but also expand its applications in various clinical settings. As a result, the market is anticipated to grow at a compound annual growth rate of 4.67% from 2025 to 2035, indicating a robust future for the Global Lithotripsy Market Industry.

Regulatory Support and Reimbursement Policies

Supportive regulatory frameworks and favorable reimbursement policies are crucial drivers of the Global Lithotripsy Market Industry. Governments and health insurance providers are increasingly recognizing the cost-effectiveness of lithotripsy as a treatment option for kidney stones. This recognition leads to improved reimbursement rates for lithotripsy procedures, making them more accessible to patients. As reimbursement policies evolve to support innovative treatment modalities, the market is likely to see an uptick in lithotripsy utilization. This trend underscores the importance of regulatory support in fostering growth within the Global Lithotripsy Market Industry.

Aging Population and Increased Healthcare Access

The aging global population is a significant factor influencing the Global Lithotripsy Market Industry. Older adults are more susceptible to developing kidney stones due to various physiological changes and comorbidities. As healthcare access improves in many regions, more elderly patients are likely to seek treatment for urolithiasis. This demographic shift is expected to drive demand for lithotripsy services, as healthcare providers adapt to the needs of an aging population. The Global Lithotripsy Market Industry stands to benefit from this trend, as the number of procedures performed is likely to increase in response to the growing patient base.

Market Segment Insights

By Application: Ureteral Stones (Largest) vs. Renal Stones (Fastest-Growing)

In the Lithotripsy Market, the application segment is significantly categorized into Ureteral Stones, Renal Stones, Biliary Stones, and Pancreatic Stones. Ureteral Stones hold the largest market share due to their higher prevalence and the effectiveness of lithotripsy in treatment. Conversely, Renal Stones are rapidly gaining attention, making them the fastest-growing segment as advancements in technology improve treatment outcomes, leading to increased adoption of lithotripsy procedures for these stones.

Ureteral Stones: Dominant vs. Renal Stones: Emerging

Ureteral Stones are positioned as the dominant segment within the Lithotripsy Market, primarily attributed to the frequency of occurrence and the widely adopted lithotripsy techniques for effective treatment. These stones often require timely medical intervention if they obstruct the urinary tract, thus increasing the demand for lithotripsy procedures. On the other hand, Renal Stones present an emerging opportunity, propelled by growing awareness and advancements in lithotripsy technology. As healthcare practitioners become more equipped to handle renal stones with less invasive methods, this segment is anticipated to witness a surge in procedures, thereby driving market dynamics.

By Technology: Laser Lithotripsy (Largest) vs. Electrohydraulic Lithotripsy (Fastest-Growing)

In the Lithotripsy Market, Laser Lithotripsy holds the largest market share due to its effectiveness and precision in fragmenting kidney stones. It is widely preferred by healthcare professionals for its minimally invasive nature and lower recovery times compared to other technologies. Electrohydraulic Lithotripsy follows closely, commanding a significant portion of the market as well, owing to its reliability and established efficacy in various clinical applications. Growth trends in this segment are largely driven by advancements in laser technologies and increasing patient preference for less invasive procedures. Additionally, the rise in kidney stone incidences and the adoption of outpatient treatments further fuel the growth of Electrohydraulic Lithotripsy. As more healthcare providers invest in modern equipment, the trend toward Laser Lithotripsy is expected to continue growing, solidifying its dominant position in the market.

Technology: Laser Lithotripsy (Dominant) vs. Electrohydraulic Lithotripsy (Emerging)

Laser Lithotripsy stands out as the dominant technology in the lithotripsy market, characterized by its ability to deliver high-energy laser pulses that precisely target and fragment stones. This method results in minimal damage to surrounding tissues, providing quick recovery for patients. It is favored in many urological procedures due to its adaptability in treating various stone sizes and compositions. In contrast, Electrohydraulic Lithotripsy is emerging as a competitive technology, blending traditional methods with modern advancements. It utilizes high-voltage electrical discharges to create shock waves for stone disintegration, offering effective results. Despite being less popular than laser techniques, its growing use in clinics showcases a shift towards incorporating diverse lithotripsy methods, indicating a robust expansion in treatment options.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the lithotripsy market, hospitals dominate the end-user segment, accounting for a significant share of the overall market. Their extensive infrastructure, specialized equipment, and skilled healthcare professionals make them the preferred choice for many patients requiring lithotripsy procedures. This substantial market share showcases the reliance on hospitals for advanced medical treatments, establishing them as the backbone of the lithotripsy service delivery. On the other hand, ambulatory surgical centers have begun to carve out a niche, gaining popularity for their ability to provide efficient, outpatient lithotripsy services at a lower cost, attracting more patients seeking quick recovery and reduced hospital stays.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

Hospitals have solidified their position as the dominant force in the lithotripsy market due to their comprehensive service offerings and capacity to perform complex procedures. They benefit from robust funding, technology, and a wide range of specialists, ensuring high-quality patient care. Meanwhile, specialty clinics represent an emerging segment characterized by their focused approach to lithotripsy and similar procedures. These clinics often offer personalized care, appealing to patients who prefer a more tailored experience. Their growth is fueled by the increasing demand for outpatient services and the quest for more accessible treatment options, allowing them to challenge traditional hospital settings.

By Procedure Type: Extracorporeal Shock Wave Lithotripsy (Largest) vs. Ureteroscopy (Fastest-Growing)

In the lithotripsy market, the procedure types exhibit varied market share distributions, with Extracorporeal Shock Wave Lithotripsy (ESWL) leading due to its non-invasive nature, making it the preferred choice among patients and healthcare providers. Percutaneous Nephrolithotomy (PCNL) holds a significant share as well, particularly for larger stones, but is less commonly chosen than ESWL. Ureteroscopy, while smaller in market share, is gaining traction driven by its effectiveness in treating urinary stones without significant recovery time, appealing to patients seeking faster results. Growth trends in the lithotripsy market are increasingly favoring Ureteroscopy, which is being seen as the fastest-growing procedure due to advancements in instrument technology and increased awareness of minimally invasive techniques. Factors contributing to growth include a rising prevalence of kidney stones and a growing emphasis on patient comfort and satisfaction. The development of innovative ureteroscopic instruments enhances procedural outcomes, further supporting Ureteroscopy's ascent in market share amidst evolving healthcare needs.

Extracorporeal Shock Wave Lithotripsy (Dominant) vs. Ureteroscopy (Emerging)

Extracorporeal Shock Wave Lithotripsy (ESWL) is the dominant procedure in the lithotripsy market, favored for its non-invasive approach and patient convenience. It employs shock waves to break kidney stones into smaller fragments, facilitating easier passage through the urinary tract. On the other hand, Ureteroscopy is emerging as a crucial alternative, especially for management of ureteral stones. While it involves the insertion of a thin tube through the urinary tract, advancements in technology have made it more effective and appealing. Ureteroscopy's growth is supported by increasing rates of urinary stone disease and a desire for quicker recovery times, positioning it as an essential player in the evolving lithotripsy landscape.

By Patient Demographics: Adult Patients (Largest) vs. Geriatric Patients (Fastest-Growing)

In the Lithotripsy Market, adult patients represent the largest segment, commanding a significant portion of the overall market share. This demographic encompasses individuals between the ages of 18 and 65, who frequently experience kidney stones due to lifestyle and dietary factors. Conversely, pediatric patients make up a smaller percentage compared to adults, while geriatric patients are witnessing a growing presence in the market as the aging population increasingly suffers from urological issues related to kidney stones. This shift highlights the importance of addressing a more diverse patient demographic in lithotripsy treatment options. Growth trends indicate that while adult patients remain the dominant demographic, geriatric patients are emerging as the fastest-growing segment. The rise in kidney stone prevalence within the elderly population, coupled with advancements in minimally invasive lithotripsy technologies, is driving the growth of this segment. Increased awareness, improved healthcare access, and innovations in treatment protocols are further contributing to the growth of geriatric patients in the lithotripsy market, which is critical for market players to consider for future strategic development.

Adult Patients (Dominant) vs. Pediatric Patients (Emerging)

The Lithotripsy Market sees adult patients as the dominant segment, largely due to their higher occurrence of kidney stones associated with dietary habits, dehydration, and lifestyle choices prevalent in this age group. Adult patients benefit from a variety of lithotripsy techniques, such as extracorporeal shock wave lithotripsy (ESWL) and laser lithotripsy, which have proven to be highly effective for stone fragmentation. In contrast, pediatric patients, while emerging, represent a smaller but significant portion of the market. The complexities of treating kidney stones in children require specialized approaches and pediatric expertise, presenting both challenges and opportunities for market growth. As the understanding of pediatric urology expands, tailored treatments for children will likely evolve, enhancing their position in the lithotripsy landscape.

Get more detailed insights about Lithotripsy Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America is poised to maintain its leadership in the lithotripsy market, holding a significant market share of $874.66M in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of urolithiasis, and rising demand for minimally invasive procedures. Regulatory support and innovation in medical technologies further catalyze market expansion, ensuring that North America remains at the forefront of lithotripsy advancements. The competitive landscape in North America is robust, featuring key players such as Boston Scientific, Medtronic, and Stryker Corporation. These companies are investing heavily in R&D to enhance their product offerings and improve patient outcomes. The presence of established healthcare systems and a high rate of adoption of new technologies contribute to the region's dominance, making it a focal point for lithotripsy innovations.

Europe : Emerging Market with Growth Potential

Europe's lithotripsy market is valued at $525.6M, reflecting a growing demand for advanced urological treatments. The region benefits from a well-established healthcare system and increasing awareness of lithotripsy procedures. Regulatory bodies are actively promoting the adoption of innovative technologies, which is expected to drive market growth. The rising incidence of kidney stones and the demand for non-invasive treatment options are key factors contributing to this upward trend. Leading countries in Europe include Germany, France, and the UK, where major players like Siemens Healthineers and Richard Wolf GmbH are prominent. The competitive landscape is characterized by strategic partnerships and collaborations aimed at enhancing product offerings. The presence of a skilled workforce and advanced research facilities further strengthens Europe's position in the lithotripsy market.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific region is witnessing a surge in the lithotripsy market, currently valued at $270.0M. Factors such as rising healthcare expenditure, increasing awareness of urological disorders, and a growing aging population are driving demand. Governments are investing in healthcare infrastructure, which is expected to enhance access to lithotripsy treatments. The region's market is characterized by a shift towards minimally invasive procedures, aligning with global healthcare trends. Countries like Japan, China, and India are leading the charge in this market, with key players such as Olympus Corporation and Cook Medical making significant inroads. The competitive landscape is evolving, with local manufacturers emerging alongside established global companies. This dynamic environment is fostering innovation and improving patient access to lithotripsy technologies, positioning Asia-Pacific as a key player in the global market.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region, with a market size of $79.07M, presents significant growth potential in the lithotripsy sector. Factors such as increasing healthcare investments, rising prevalence of kidney stones, and a growing focus on advanced medical technologies are driving market growth. Governments are prioritizing healthcare improvements, which is expected to enhance access to lithotripsy treatments across the region. Leading countries in this region include South Africa and the UAE, where healthcare systems are evolving rapidly. The competitive landscape is characterized by a mix of local and international players, with companies like ConMed Corporation and B. Braun Melsungen AG expanding their presence. The region's unique challenges and opportunities create a dynamic environment for innovation and growth in lithotripsy technologies.

Lithotripsy Market Regional Image

Key Players and Competitive Insights

The Lithotripsy Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of urolithiasis. Key players such as Boston Scientific (US), Medtronic (US), and Siemens Healthineers (DE) are strategically positioned to leverage innovation and expand their market presence. Boston Scientific (US) focuses on enhancing its product portfolio through continuous innovation, while Medtronic (US) emphasizes strategic partnerships to bolster its technological capabilities. Siemens Healthineers (DE) is investing in digital transformation initiatives, which collectively shape a competitive environment that prioritizes advanced solutions and patient-centric care.The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which enhances operational efficiency. The collective influence of these major companies fosters a competitive atmosphere where innovation and strategic collaborations are paramount.
In November Boston Scientific (US) announced the launch of a new lithotripsy device that integrates AI technology to enhance treatment precision. This strategic move is significant as it positions the company at the forefront of technological innovation, potentially improving patient outcomes and operational efficiencies in urology practices. The integration of AI could also streamline workflows, making it a compelling offering in a competitive market.
In October Medtronic (US) entered into a partnership with a leading telehealth provider to enhance remote patient monitoring capabilities for lithotripsy patients. This collaboration is crucial as it reflects a growing trend towards digital health solutions, enabling better patient management and follow-up care. By integrating telehealth services, Medtronic (US) is likely to improve patient engagement and satisfaction, which could translate into increased market share.
In September Siemens Healthineers (DE) unveiled a new digital platform designed to optimize lithotripsy procedures through real-time data analytics. This initiative is indicative of the company's commitment to digitalization, which is becoming increasingly vital in the healthcare sector. By harnessing data analytics, Siemens Healthineers (DE) aims to enhance procedural efficiency and patient safety, thereby reinforcing its competitive position in the market.
As of December current trends in the Lithotripsy Market are heavily influenced by digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, advanced technology, and reliable supply chains. This shift suggests that companies that prioritize these aspects will be better positioned to thrive in an increasingly complex market.

Key Companies in the Lithotripsy Market include

Industry Developments

  • Q2 2024: Boston Scientific launches next-generation LithoVue Elite Single-Use Digital Flexible Ureteroscope Boston Scientific announced the commercial launch of its LithoVue Elite Single-Use Digital Flexible Ureteroscopein the U.S., designed to enhance stone management procedures with real-time intrarenal pressure monitoring.
  • Q2 2024: Olympus launches Soltive SuperPulsed Laser System for stone management in Europe Olympus introduced the Soltive SuperPulsed Laser System in select European markets, expanding its portfolio for minimally invasive lithotripsy and stone management.
  • Q3 2024: Dornier MedTech receives FDA clearance for Delta III Lithotripter Dornier MedTech announced FDA clearance for its Delta III Lithotripter, enabling expanded use of its shock wave technology for non-invasive kidney stone treatment in the U.S.
  • Q2 2024: Philips and Shockwave Medical announce strategic partnership to advance intravascular lithotripsy Philips and Shockwave Medical entered a strategic partnership to integrate intravascular lithotripsy technology with Philips' imaging systems, aiming to improve treatment of calcified cardiovascular lesions.
  • Q1 2025: Shockwave Medical receives CE Mark for Shockwave C2+ Coronary IVL Catheter Shockwave Medical announced CE Mark approval for its Shockwave C2+ Coronary IVL Catheter, allowing commercialization of the device for treating calcified coronary arteries in Europe.
  • Q2 2024: Medtronic acquires LithoTech Medical for $150 million Medtronic completed the acquisition of LithoTech Medical, a developer of advanced lithotripsy devices, to strengthen its urology and kidney stone management portfolio.
  • Q3 2024: FDA approves new indication for Boston Scientific's LithoVue Elite for pediatric use The FDA granted approval for Boston Scientific's LithoVue Elite Single-Use Digital Flexible Ureteroscope for use in pediatric patients, expanding its clinical applications.
  • Q2 2025: Olympus opens new manufacturing facility for lithotripsy devices in Germany Olympus inaugurated a new manufacturing facility in Germany dedicated to the production of lithotripsy devices, aiming to meet growing European demand.
  • Q1 2025: Shockwave Medical announces $100 million Series D funding round Shockwave Medical raised $100 million in a Series D funding round to accelerate development and commercialization of its intravascular lithotripsy technology.
  • Q2 2024: Dornier MedTech partners with Siemens Healthineers to integrate imaging with lithotripsy systems Dornier MedTech and Siemens Healthineers formed a partnership to integrate advanced imaging capabilities with Dornier's lithotripsy systems for improved stone localization and treatment outcomes.
  • Q3 2024: Boston Scientific appoints Dr. Lisa Chen as Global Head of Urology Division Boston Scientific announced the appointment of Dr. Lisa Chen as Global Head of its Urology Division, overseeing the company's lithotripsy and stone management business.
  • Q1 2025: Philips launches new ultrasound-guided lithotripsy platform in Asia-Pacific Philips introduced a new ultrasound-guided lithotripsy platform in select Asia-Pacific markets, targeting improved outcomes for kidney stone patients.

Future Outlook

Lithotripsy Market Future Outlook

The Lithotripsy Market is projected to grow at a 5.15% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of urolithiasis, and rising healthcare expenditure.

New opportunities lie in:

  • Development of portable lithotripsy devices for outpatient settings. Expansion of telehealth services for remote lithotripsy consultations. Investment in AI-driven imaging technologies to enhance treatment precision.

By 2035, the Lithotripsy Market is expected to achieve substantial growth and innovation.

Market Segmentation

Lithotripsy Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Lithotripsy Market Technology Outlook

  • Electrohydraulic Lithotripsy
  • Laser Lithotripsy
  • Ultrasonic Lithotripsy
  • Mechanical Lithotripsy

Lithotripsy Market Application Outlook

  • Ureteral Stones
  • Renal Stones
  • Biliary Stones
  • Pancreatic Stones

Report Scope

MARKET SIZE 2024 1749.33(USD Million)
MARKET SIZE 2025 1859.47(USD Million)
MARKET SIZE 2035 3052.63(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.15% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Olympus Corporation (JP), Richard Wolf GmbH (DE), Cook Medical (US), ConMed Corporation (US), Stryker Corporation (US), B. Braun Melsungen AG (DE)
Segments Covered Application, Technology, End User
Key Market Opportunities Advancements in non-invasive technologies enhance treatment efficacy in the Lithotripsy Market.
Key Market Dynamics Technological advancements in lithotripsy devices drive competitive dynamics and enhance treatment efficacy in urology.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Lithotripsy Market as of 2024?

The Lithotripsy Market was valued at 1749.33 USD Million in 2024.

What is the projected market valuation for the Lithotripsy Market in 2035?

The market is projected to reach 3052.63 USD Million by 2035.

What is the expected CAGR for the Lithotripsy Market during the forecast period 2025 - 2035?

The expected CAGR for the Lithotripsy Market during 2025 - 2035 is 5.15%.

Which companies are considered key players in the Lithotripsy Market?

Key players include Boston Scientific, Siemens Healthineers, Medtronic, Johnson & Johnson, and Olympus Corporation.

What are the primary applications of lithotripsy in the market?

The primary applications include Ureteral Stones, Renal Stones, Biliary Stones, and Pancreatic Stones.

How does the market segment by technology for lithotripsy?

The market segments by technology include Electrohydraulic Lithotripsy, Laser Lithotripsy, Ultrasonic Lithotripsy, and Mechanical Lithotripsy.

What are the end-user segments in the Lithotripsy Market?

End-user segments consist of Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.

What procedure types are included in the Lithotripsy Market?

Procedure types include Percutaneous Nephrolithotomy, Extracorporeal Shock Wave Lithotripsy, and Ureteroscopy.

How is the Lithotripsy Market segmented by patient demographics?

The market is segmented by patient demographics into Adult Patients, Pediatric Patients, and Geriatric Patients.

What is the valuation range for Ureteral Stones in the Lithotripsy Market?

The valuation range for Ureteral Stones is between 300.0 and 500.0 USD Million.

Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed urology and medical device journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA) Medical Device Coordination Group (MDCG), European Commission Medical Device Regulation (MDR) database, International Urology Society (SIU), American Urological Association (AUA), European Association of Urology (EAU), Endourological Society, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Center for Biotechnology Information (NCBI/PubMed), CDC National Center for Health Statistics (NCHS) National Health and Nutrition Examination Survey (NHANES), World Health Organization (WHO) Global Health Observatory, EU Eurostat Health Database, Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule, National Health Service (NHS) England Device and Technology Registry, Japan Ministry of Health, Labour and Welfare (MHLW) Medical Device Database, Health Canada Medical Devices Active Licence Listing (MDALL), Therapeutic Goods Administration (TGA) Australia, and national health ministry reports from key markets. These sources were used to collect urolithiasis epidemiology data, regulatory approval data for lithotripters and endourology devices, clinical safety and efficacy studies, reimbursement codes and policies, demographic trends in kidney stone prevalence, and market landscape analysis for extracorporeal shock wave lithotripsy (ESWL), laser lithotripsy, percutaneous lithotripsy, and ureteroscopic lithotripsy technologies.

Additional specialized sources included the American College of Radiology (ACR) Appropriateness Criteria, Society of Interventional Radiology (SIR), International Society for Medical Shockwave Treatment (ISMST), Kidney Stone Disease Research Network, National Kidney Foundation (NKF), and urology procedure registries from major academic medical centers.

Primary Research

In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, R&D directors, and commercial directors from makers of lithotripsy devices, shock wave generator OEMs, laser system developers, and endoscope manufacturers were examples of supply-side sources. Board-certified urologists, interventional radiologists, endourologists, medical directors of ambulatory surgery facilities, procurement leads from hospital urology departments, and administrators of specialist stone clinics were among the demand-side sources. Market segmentation across procedure types (ESWL, laser lithotripsy, percutaneous lithotripsy, ureteroscopic lithotripsy), technology categories (electromechanical lithotripters, laser lithotripters, ultrasound lithotripters), end-user settings (hospitals, ambulatory surgical centers, specialty clinics), and stone types (calcium oxalate, uric acid, struvite, and cystine) was confirmed by primary research. Additionally, it gathered information on clinical adoption patterns of minimally invasive stone management, pricing strategies for capital equipment and disposables, reimbursement dynamics across public and private payers, and confirmed product pipeline timelines for next-generation lithotripsy devices.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Global market valuation was derived through revenue mapping, procedure volume analysis, and installed base estimation. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America, including Boston Scientific, Medtronic, Siemens Healthineers, Olympus Corporation, Richard Wolf GmbH, Cook Medical, ConMed Corporation, Stryker Corporation, B. Braun Melsungen AG, Dornier MedTech, EDAP TMS, and emerging regional players

Product mapping across electrohydraulic lithotripsy, laser lithotripsy, ultrasonic lithotripsy, and mechanical lithotripsy technology platforms

Analysis of reported and modeled annual revenues specific to lithotripsy device portfolios, including capital equipment sales, consumables, and service contracts

Coverage of manufacturers representing 72-78% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country/region, segmented by ESWL, laser, percutaneous, and ureteroscopic procedures) and top-down (manufacturer revenue validation across device categories) approaches to derive segment-specific valuations

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.